AbbVie Invests $195M to Expand U.S. Pharmaceutical Manufacturing
AbbVie announced a $195 million investment to expand its active pharmaceutical ingredient (API) manufacturing capacity in North Chicago, Illinois, as part of a broader plan to invest over $10 billion in the U.S. over the next decade, supporting the production of innovative medicines and creating jobs.